MTOR and Miyoshi myopathy: The coexistence of RCC and MM within the same bone lesions may be partly explained by their reliance on common oncogenic signaling pathways, particularly the PI3K/AKT/mTOR pathway, which regulates cell growth, survival, metabolism, and disease progression in both malignancies [16,17].